UPDATE 2-ValueAct returns to Valeant board, plans to raise stake
September 25, 2014 at 20:20 PM EDT
Sept 25 (Reuters) - Hedge fund ValueAct Capital said on Thursday it would return to the board of directors of Valeant Pharmaceuticals International Inc, which is pursuing a hostile takeover offer for Allergan Inc, and that it planned to increase its stake in the company.